Spain is close to ten million COVID infections since the start of the pandemic and the incidence drops almost 200 points after the weekend

The incidence drops almost 200 points to 2,879.95 cases per 100,000 inhabitants after the weekend, while Spain is already close to 10 million coronavirus infections since the beginning of the pandemic. The curve has been trending downward for days: last Monday the rate stood at 3,381.16 cases per 100,000 inhabitants. However, it must be taken into account, as the latest report from the Ministry of Health warns, that Aragón has not updated its data.

People aged 11 and under report the highest incidence rate of all age groups, with 5,461.47 cases per 100,000 population. On the other hand, people over 50 years of age are the ones who report a lower rate: no group registers more than 2,000 cases per 100,000 inhabitants.

After the weekend, the Ministry of Health adds 182,123 coronavirus infections. In total, 9,961,253 infections by the pathogen have been registered since the epidemiological situation began, with which Spain is heading towards 10 million infected.

Hospital data rose slightly after the weekend and hospital pressure was once again at "very high" risk levels, with 15.05% of beds occupied by COVID patients. The same happens with the percentage of occupancy in the ICU, which goes from 21.77% on Friday to 22.28% this Monday.

Since Friday, 259 deaths from COVID-19 have been reported, bringing the total number of deaths to 93,225 people.

Drugs potentially capable of reducing mortality associated with COVID-19

Inflammation is a defense of the body to fight against pathogens. However, when it occurs in an excessive and generalized way, it can aggravate the pathology and even cause death.

One of the ways this over-response occurs is known as a cytokine storm, an inflammatory process caused by these proteins, cytokines, signaling the immune system to activate.

"This response is the one that frequently kills those affected by SARS-CoV-2, and not so much the virus itself", explains Óscar Fernández-Capetillo, head of the Genomic Instability Group of the National Cancer Research Center (CNIO).

Source link